University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
NCT Number: NCT00955903
The investigators want to determine if the benefits of weight loss outweigh the potential risk in a group of older adults. The investigators will test the hypothesis that changes in diet composition alone or in conjunction with weight loss will have a significant effect on fat stores, and as a result, improve cardiometabolic risk factors and functional status in adults 65 and older.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Phase 3
Birmingham, Alabama, 35294, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will participate in supervised exercise sessions
Participants will follow a reduced calorie diet
Participants will follow a weight maintenance diet
Time frame: Baseline to 1 year
Visceral adipose tissue (cm3) by MRI. Change is calculated as value at baseline minus value at 1 year
Time frame: Baseline to 1 year
We are reporting change in blood glucose. Change is calculated as value at baseline minus value at 1 year
Time frame: Baseline to 1 year
The change in body weight at follow up of 1 year. Change is calculated as value at baseline minus value at 1 year
University of Alabama at Birmingham
Other
Acronym: CROSSROADS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01642355
Arterial Occlusive Diseases, Arteriosclerosis
New York, United States
View Trial DetailsNCT01647438
Behavior, Body Weight
Chicago, Illinois, United States
View Trial DetailsNCT00882336
Behavior, Body Weight
Alland, Austria
View Trial DetailsNCT00236210
Arterial Occlusive Diseases, Arteriosclerosis
Sault Ste. Marie, Ontario, Canada
View Trial Details